John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
951
DELISTED
Abiomed Inc
ABMD
| $3.06M | 0.01% |
12,438
-23,149
| -65% | -$6.25M |
|
952
Health Catalyst
HCAT
$120M
| $3.02M | 0.01% |
310,798
-115,818
| -27% | -$1.53M |
|
953
Kodiak Sciences
KOD
$2.34B
| $3M | 0.01% |
387,660
+150,536
| +63% | +$1.46M |
|
954
Twist Bioscience
TWST
$8.83B
| $3M | 0.01% |
+85,001
| New | +$3.61M |
|
955
Cirrus Logic
CRUS
$5.6B
| $2.99M | 0.01% |
43,448
-3,643
| -8% | -$286K |
|
956
Vulcan Materials
VMC
$35.8B
| $2.99M | 0.01% |
18,937
-14,175
| -43% | -$2.3M |
|
957
Virgin Galactic
SPCE
$455M
| $2.99M | 0.01% |
31,694
-6,131
| -16% | -$787K |
|
958
PUT
Akamai
AKAM
$15.2B
| $2.98M | 0.01% |
37,100
+15,100
| +69% | +$1.37M |
|
959
Franklin Covey
FC
$232M
| $2.95M | 0.01% |
65,030
+25,912
| +66% | +$1.28M |
|
|
DENN
960
DELISTED
Denny's
DENN
| $2.94M | 0.01% |
312,857
+261,639
| +511% | +$2.51M |
|
|
INBX
961
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.94M | 0.01% |
163,489
+39,264
| +32% | +$708K |
|
962
VICI Properties
VICI
$29.5B
| $2.93M | 0.01% |
+98,238
| New | +$3.24M |
|
963
Trustmark
TRMK
$2.7B
| $2.92M | 0.01% |
95,323
-66,039
| -41% | -$2.09M |
|
964
Hancock Whitney
HWC
$6.01B
| $2.92M | 0.01% |
63,704
+42,487
| +200% | +$2.04M |
|
965
MSC Industrial Direct
MSM
$6.66B
| $2.91M | 0.01% |
39,964
-30,288
| -43% | -$2.39M |
|
966
Cactus
WHD
$5.46B
| $2.91M | 0.01% |
75,656
+57,489
| +316% | +$2.3M |
|
967
Ceco Environmental
CECO
$4.18B
| $2.88M | 0.01% |
325,270
+201,820
| +163% | +$1.73M |
|
968
Capital Southwest
CSWC
$1.61B
| $2.88M | 0.01% |
169,947
-90,352
| -35% | -$1.74M |
|
|
HPP
969
Hudson Pacific Properties
HPP
$798M
| $2.87M | 0.01% |
37,404
+15,457
| +70% | +$1.5M |
|
970
Clearwater Paper
CLW
$343M
| $2.86M | 0.01% |
76,115
+29,716
| +64% | +$1.18M |
|
971
Rocket Lab Corp
RKLB
$43.7B
| $2.86M | 0.01% |
703,224
-1,768,903
| -72% | -$8.73M |
|
972
The Joint Corp
JYNT
$119M
| $2.86M | 0.01% |
182,135
-67,425
| -27% | -$1.2M |
|
973
Kura Sushi USA
KRUS
$603M
| $2.85M | 0.01% |
+38,791
| New | +$2.99M |
|
974
Ardmore Shipping
ASC
$746M
| $2.84M | 0.01% |
+311,124
| New | +$2.77M |
|
|
MRC
975
DELISTED
MRC Global
MRC
| $2.84M | 0.01% |
394,758
-169,458
| -30% | -$1.67M |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.